Infectious risk stratification in multiple sclerosis patients receiving immunotherapy

MLA

Graf, Jonas, et al. Infectious Risk Stratification in Multiple Sclerosis Patients Receiving Immunotherapy. 2017. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsoai&AN=edsoai.on1201321523&authtype=sso&custid=ns315887.

APA

Graf, J., Leussink, V. I., Dehmel, T., Ringelstein, M., Goebels, N., Adams, O., MacKenzie, C. R., Warnke, C., Feldt, T., Lammerskitten, A., Klotz, L., Meuth, S., Wiendl, H., Hartung, H.-P., Aktas, O., & Albrecht, P. (2017). Infectious risk stratification in multiple sclerosis patients receiving immunotherapy.

Chicago

Graf, Jonas, Verena I. Leussink, Thomas Dehmel, Marius Ringelstein, Norbert Goebels, Ortwin Adams, Colin R. MacKenzie, et al. 2017. “Infectious Risk Stratification in Multiple Sclerosis Patients Receiving Immunotherapy.” http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsoai&AN=edsoai.on1201321523&authtype=sso&custid=ns315887.